Eight of the 101 (7.9%) of laryngeal tumors were considered to be positive for p16 based on the criteria of strong, diffuse p16 staining of the nucleus and cytoplasm in ≥70% of tumor cells. Here, CDKN2A is linked to laryngeal neoplasm.